chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt was contacted after another pt that we had seen on the same day as she was seen received a pneumococcal vaccination and subsequently developed a large cellulitis/ abscess. We contacted all of the patients who received the vaccine from that same lot and out of all of them, the pt was the only other one with any kind of discomfort. Had some mild pain the evening after the vaccination which worsened over the course of the night and peaked yesterday. No fever, chills or other systemic symptoms. She feels that the pain is 90% better. Does have some slight tenderness in the left deltoid area along with some slight swelling but really not very impressive. Good range of motion limitation. A local reaction to pneumococcal vaccination-- I do not really see much compelling evidence for infection but we'll obviously maintain a low threshold for this. The pneumococcal vaccination that we administered was in unit dose form and the likelihood of the whole lot being contaminated would seem to be small. Nonetheless I have encouraged her to contact me or my partners immediately should she develop any swelling, increased pain, fever, chills, or any questions whatsoever. I wasn't sure if she fully understood the ramifications of all of this and I tried to contact her daughter at the contact number that was given that was given but her daughter was not there. Message left with the son in law.
2yr old female presented to office for injection flu vaccine - Given 0.25 FLUZONE IM (R) thigh - approx 20 min later child had few hive like lesion (1) top of foot, (1) abdomen, (1) back. Given some DECADRON IM and 12.5 BENADRYL PO.
This spontaneous report as received from the patient's husband refers to a 57 year old female patient. The patient's current conditions included asthma, and drug reaction/allergy to penicillin "any-cillin", and IV dye and historical condition of multiple sclerosis. On 20-OCT-2010, the patient was vaccinated with a dose of ZOSTAVAX vial, (dose, route, lot number and expiration date were not reported). The patient's husband stated that after receiving ZOSTAVAX on 27-OCT-2010, the patient had a relapse of her multiple sclerosis (MS). The patient had gone to the hospital on an unspecified date for this relapse. Then "three days later" the patient was discharged. After the patient was discharged, the patient was not improving. Since the patient was not improving, the patient was admitted to different hospital on an unspecified date and stayed there for 2 weeks. The patient was still trying to recover from this relapse. The patient saw a physician for medical attention. Additional information has been requested.
I still have pain in my right arm 3 months later. I have weakness. A radiating warmth, throbbing pain that makes it difficult to sleep. The weakness goes all the way to my wrist and to my neck on occasion. It has not gotten better over time.
left armpit lymph node swelling and pain (could not wear bra), nausea, headache, dizziness, back of left arm pain, and pain radiating to the neck and under the jaw, general fatigue and malaise. Visited ER for symptoms of back of left arm pain and radiating neck pain to rule out heart condition. The arm pain and lymph node pain resolved but continue to have nausea and headache.
heart racing; fluttering; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 19-year-old female patient received BNT162b2 (BNT162B2), in May2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PALPITATIONS (non-serious), outcome "unknown", described as "heart racing"; ATRIAL FLUTTER (non-serious), outcome "unknown", described as "fluttering".  Additional information: The caller states her 19-year-old daughter got the Pfizer BioNTech COVID-19 vaccine in May2021 and had some heart racing and fluttering issues that were not immediate after the administration of the vaccine. These symptoms, that happened when the callers daughter was 17 years old, were attributed by the cardiologist to stress, anxiety and dehydration however, caller states that upon checking the VAERS reports, the lot numbers that her daughter was administered (EW0170 and FK9729) counted more that 3000 reports of side effects while her mother-in-law three lot numbers had only 124 reports. She now has learned to manage the anxiety a lot better, she was drinking the water she should, and she is still having these problems. Caller also states, Your fact sheet should be more factual.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300046233 same patient/vaccine/event, different doses;US-PFIZER INC-202300046234 same patient/vaccine/event, different doses;
Expired vaccine used (Expiration: 01Jan2021); have not taken the second dose; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used (Expiration: 01Jan2021)) and PRODUCT DOSE OMISSION ISSUE (have not taken the second dose) in a 28-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included IBUPROFEN (MOTRIN [IBUPROFEN]) and PARACETAMOL (TYLENOL) for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used (Expiration: 01Jan2021)) and PRODUCT DOSE OMISSION ISSUE (have not taken the second dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used (Expiration: 01Jan2021)) and PRODUCT DOSE OMISSION ISSUE (have not taken the second dose) outcome was unknown. Not Provided    Treatment medication was not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
administered with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 28-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided.  Date the vial was initially stored in the refrigerator was 25-Mar-2022, 8:00am  The vial did not undergo any temperature excursions.  No treatment information provided.
First dose 5 months ago / can i now take the 2nd dose; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (First dose 5 months ago / can i now take the 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (First dose 5 months ago / can i now take the 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (First dose 5 months ago / can i now take the 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. No treatment medication were reported.
p/vax pt devel pain in wrist (joints) & numbness on fingers (rt hand);progressed to both knees (joint pains) got worse as time passed;pt got therapy for hand to get strength back;cont pain;hard time remembering things;
pt got shot at 11.45 am, at 11.47 am, pt felt lightheadedness, dizziness, sweating. we gave him water and elevated his feet to a chair. after 3 minutes, he left the immunization room, and pt was on the observation area for 20 minutes. pt mom was with him. on the vaccination adm record and concent form: the pt denies any: has the person vaccinated had a reaction or fainted, or felt dizzy after receiving any vaccination, pt said no. these is ask also , before the pt is admi the injections. We talk to mom, and told her to look for any shortness of breath , hives, rashes to take him to hospital
Information has been received from a nurse concerning a 15 weeks old female patient who on 01-SEP-2010 was vaccinated orally with the first dose of 2ml ROTATEQ (lot # 663681/0016Y, expiration date 30-OCT-2010). On 30-NOV-2010 the patient received second dose of ROTATEQ that had expired on 30-OCT-2010. No adverse experience known. No treatment was given for the events. The patient did not seek medical attention. Additional information has been requested.
The vaccine was given in the morning due to receiving  the notice to stop administering the vaccine  around 4:00 P:M.
Got 2nd dose on 24 day interval; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got 2nd dose on 24 day interval) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got 2nd dose on 24 day interval). On 23-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got 2nd dose on 24 day interval) had resolved.            No relevant concomitant medications were reported. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.  Company Comment: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot number: Unknown) with no associated AEs.   Reporter did not allow further contact
Very winded; Sick; I didn't get my 2nd dose yet.; Feverous; She was tired; This spontaneous case was reported by a nurse and describes the occurrence of DYSPNOEA (Very winded), ILLNESS (Sick), PRODUCT DOSE OMISSION ISSUE (I didn't get my 2nd dose yet.), PYREXIA (Feverous) and FATIGUE (She was tired) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Very winded), ILLNESS (Sick), PRODUCT DOSE OMISSION ISSUE (I didn't get my 2nd dose yet.), PYREXIA (Feverous) and FATIGUE (She was tired). At the time of the report, DYSPNOEA (Very winded), ILLNESS (Sick), PRODUCT DOSE OMISSION ISSUE (I didn't get my 2nd dose yet.), PYREXIA (Feverous) and FATIGUE (She was tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medications were not reported. The treatment information was not provided.
Pt had DTaP administered on 4/19/10. Pt came in with a 9 x 6.75 cm reaction with warmth and redness to (R) deltoid.
Information has been received from an employee at a physician's office concerning a 5-year-old white female who on 09-MAY-2001 was vaccinated SC with a second dose of varicella virus vaccine live.  On 06-FEB-2006, the patient developed a papulovesicular rash on the upper torso, "20 to 30", and had no fever.  The patient recovered on 13-FEB-2006.  No further information is expected.
no adverse event; Incorrect product storage; This spontaneous report was received from a office manager and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported.  On 19-MAR-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) dose/ frequency: 1,  lot # T015598, expiration date 02-NOV-2021, for prophylaxis (route were not reported).  The temperature involved was 16.5 degrees F for 4 hours. The previous temperature excursion was 14.5 degrees F for 2 hours and 45 minutes, 15.6 degrees F for 3 hours and 21 degrees F for 5 hours and 30 minutes. A data logger was involved. No adverse event.  This is one of multiples cases received from the same reporter.; Sender's Comments:  US-009507513-2104USA003878:Original Case : 2104USA003483 US-009507513-2104USA003879:Original Case : 2104USA003483 US-009507513-2104USA003880:Original Case : 2104USA003483 US-009507513-2104USA003882:Original Case : 2104USA003483 US-009507513-2104USA003883:Original Case : 2104USA003483 US-009507513-2104USA003884:Original Case : 2104USA003483 US-009507513-2104USA003885:Original Case : 2104USA003483 US-009507513-2104USA003877:Original Case : 2104USA003483 US-009507513-2104USA003876:Original Case : 2104USA003483 US-009507513-2104USA003881:Original Case : 2104USA003483
Severe pain 2 days after injection- neck & left side of upper body down arm into elbow, symptoms/pain are continuing to increase & travel down arm.  Face showing redness/rash on cheeks & chin.  Day of vaccine:  headache, sick, slept.
Loose and smelly stools/ Occasional diarrhea; Loose and smelly stools; Occasional stomach pain; flatulence; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.   A 38 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04Aug2021 14:45 (Lot number: Fc3180) at the age of 38 years as dose 1, single and administered in arm left, administration date 25Aug2021 14:45 (Lot number: FC3182) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.  The following information was reported: DIARRHOEA (non-serious) with onset 05Aug2021, outcome "not recovered", described as "Loose and smelly stools/ Occasional diarrhea"; ABNORMAL FAECES (non-serious) with onset 05Aug2021, outcome "not recovered", described as "Loose and smelly stools"; ABDOMINAL PAIN UPPER (non-serious) with onset 05Aug2021, outcome "not recovered", described as "Occasional stomach pain"; FLATULENCE (non-serious) with onset 05Aug2021, outcome "not recovered", described as "flatulence". Therapeutic measures were not taken as a result of diarrhoea, abnormal faeces, abdominal pain upper, flatulence.   Additional information: Product=COVID 19, brand=Pfizer. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications the patient received within 2 weeks of vaccination. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
Sore arm; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and FATIGUE (Very tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Very tired). At the time of the report, PAIN IN EXTREMITY (Sore arm) and FATIGUE (Very tired) outcome was unknown.            No concomitant medications were reported.   No treatment information was provided.   This case was linked to MOD-2021-026841 (Patient Link).
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild
Episcleritis in left eye in May. Hard nodules formed on multiple finger joints on both hands after sleeping over the course of a week (June 4-11); aching in hands, wrists, shoulders, hips, knees and feet. Lump forming on left wrist (June 13). Joints popping when moving. Unable to move without pain.
I had a severe allergic reaction, I ended up in the emergency room after; This is a spontaneous report from a contactable consumer (patient).   A 53-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 27Oct2021 (at the age of 53-years-old) as single dose for covid-19 immunisation. Medical history included fallot's tetralogy, hypothyroidism, blood pressure abnormal. Concomitant medications included levothyroxine taken for hypothyroidism, start and stop date were not reported; atenolol taken for blood pressure abnormal, start and stop date were not reported; quinidine gluconate taken for an unspecified indication, start and stop date were not reported.  The patient experienced a severe allergic reaction, the patient ended up in the emergency room on an unspecified date with outcome of unknown.  At the emergency room they put her on IV and they gave her fluids.  The lot number for the vaccine BNT162B2 was not provided and will be requested during follow-up.
Administered higher dose of vaccine than recommended.  Patient received 2 COVID Pfizer bivalent booster vaccine instead of 1 COVID booster dose and 1 influenza vaccine.
Information has been received from a pharmacist concerning a patient who was vaccinated with ZOSTAVAX (Merck). The patient experienced a muscle spasm in hands and fingers within 20 minutes of administration of the vaccine. The patient had sought unspecified medical attention. The outcome of the patient's muscle spasm in hands and fingers was not reported. No further information is available.
I tested positive for Covid-19 on December 19, 2022 runny nose; sore throat; cough; fever 101.7; I was prescribed Prednisone and Z-pack.
pt recv vax; exp localized soreness & redness at inject site;26mar94,lab eval showed neg for anti_HBs;recv 4th dose of vax on 11jul94;on 9aug94 lab eval showed anti HBs 146.9;
This case was reported by a physician via a sales representative and described the occurrence of swelling arm in a subject of unspecified age and gender who was vaccinated with TWINRIX (GlaxoSmithKline). In 2011 the subject received unspecified dose of TWINRIX in the left arm. At an unspecified time after vaccination with TWINRIX (starting about a week ago following vaccination), the subject experienced swelling arm, arms redness and arm pain. At the time of reporting the events were unresolved. Attribution of events to TWINRIX was not reported. No additional information was known.
Information has been received from a registered nurse regarding a patient of unknown age and gender. On 05-OCT-2011, the patient was administered with a dose of VARIVAX (Lot # 1703Z, expiry date unknown) (Route, dosing regimen and frequency unknown) which was exposed to a temperature excursion of up to -3 degrees Centigrade. No adverse events were reported. No product quality issue was reported. This is one of the many reports received from the same source. Additional information has been requested.
She has allergies; Cough like an asthmatic cough.; I sounded a little hoarse afterwards; I felt a weird feeling in my trachea; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 24Mar2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE DOSE for COVID-19 immunisation. Medical history included anaphylactic reaction in the past to mushroom & Penicillin. The patient's concomitant medications were not reported. The patient delayed her second Pfizer Covid 19 Vaccine until 24May2021 thinking the symptoms may not be too bad if any. She was asking if she should take the second Pfizer Covid 19 Vaccine. She was advised not to get the Pfizer-BioNTech COVID-19 Vaccine if she had a severe allergic reaction after a previous dose of the vaccine or had a severe allergic reaction to any ingredient of the vaccine. The patient received the first dose of Pfizer Covid 19 Vaccine on 24March2021. About 45 minutes after receiving the vaccine (24March2021), she felt a weird feeling in her trachea that immediately went away while talking with her son. She sounded a little hoarse afterwards in May2021. She also experienced a cough like an asthmatic cough in May2021. She took her inhaler and it helped. She had anaphylactic reaction in the past to mushroom & Penicillin. Her mother's allergist advised it may have been her body reacting. In May2021, she had allergies and reported walking a good distance to her car after the vaccine without her mask on. The patient also mentioned taking Antihistamine. Therapeutic measures were taken as a result of she has allergies (hypersensitivity), cough like an asthmatic cough. (cough). The event "I felt a weird feeling in my trachea" resolved on 24Mar2021, "Cough like an asthmatic cough" resolved in May2021, while the outcome of the rest of the events was unknown.   Information on the batch/lot number has been requested.
pt devel an inj site rxn characterized by heat, swelling & drainage following vax;addtl info recv 11OCT96 indicated that pt recovered;this is 1 of 3 pt from this site to have an adverse exp p/Td vax lot# 433355;
Patient came to the ED with shortness of breath, vomiting, and altered mental status.  Patient admitted to the hospital with Covid.
had some temps that night; felt bad; tremors in his head and neck; tremors in his head and neck/physical tremors; This is a spontaneous report from a contactable consumer (reporter's friend). A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 18Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date in Jan2021, the patient had tremors in his head and neck and he did go to local ER and they felt it was related to the vaccine. The patient was given a muscle relaxer and sent him home. They did a CT scan and it was normal. The patient had physical tremors. He had some temps that night and felt bad.  He was fine and then all of a sudden felt bad that night.  It was very obvious that he had tremors. Clinical outcome of the events was unknown.  Information on the lot/batch number has been requested.